Search research articles
Contact Us
Filters
Showing results (131-140 of 214) with videos related to
Page
of 22
Sort By:
Scientific Reports
|
March 20, 2026
Association of long COVID with health-related quality-of-life outcomes
Malini M Gandhi, Carlee Moser, Judith S Currier, et al.
Annals of Internal Medicine
|
February 21, 2023
Symptom and Viral Rebound in Untreated SARS-CoV-2 Infection
Rinki Deo, Manish C Choudhary, Carlee Moser, et al.
Clinical Pharmacology and Therapeutics
|
July 7, 2022
Comparative Pharmacokinetics of Tixagevimab/Cilgavimab (AZD7442) Administered Intravenously Versus Intramuscularly in Symptomatic SARS-CoV-2 Infection
Rachel A Bender Ignacio, David A Wohl, Rosalin Arends, et al.
Medrxiv : the Preprint Server for Health Sciences
|
August 19, 2022
Viral and Symptom Rebound in Untreated COVID-19 Infection
Rinki Deo, Manish C Choudhary, Carlee Moser, et al.
Medrxiv : the Preprint Server for Health Sciences
|
March 30, 2023
Statistical Challenges when Analyzing SARS-CoV-2 RNA Measurements Below the Assay Limit of Quantification in COVID-19 Clinical Trials
Carlee B Moser, Kara W Chew, Mark J Giganti, et al.
The Journal of Infectious Diseases
|
October 14, 2024
Viral and Symptom Rebound Following Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Monoclonal Antibody Therapy in a Randomized Placebo-Controlled Trial
Kara W Chew, Brooke McGinley, Carlee Moser, et al.
Eclinicalmedicine
|
September 10, 2024
Post-acute COVID-19 outcomes including participant-reported long COVID: amubarvimab/romlusevimab versus placebo in the ACTIV-2 trial
Teresa H Evering, Carlee Moser, Nikolaus Jilg, et al.
Science Immunology
|
March 27, 2021
A tumor-specific mechanism of T<sub>reg</sub> enrichment mediated by the integrin αvβ8
Robert I Seed, Kenji Kobayashi, Saburo Ito, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 17, 2024
SARS-CoV-2 Plasma Antibody and Nucleocapsid Antigen Status Predict Outcomes in Outpatients With COVID-19
Nikolaus Jilg, Mark J Giganti, Kara W Chew, et al.
Plos Pathogens
|
April 18, 2024
Modeling the emergence of viral resistance for SARS-CoV-2 during treatment with an anti-spike monoclonal antibody
Tin Phan, Carolin Zitzmann, Kara W Chew, et al.
Page
of 22
Search research articles
Search
Showing results (131-140 of 214) with videos related to
Sort By:
Page
of 22
Scientific Reports
|
March 20, 2026
Association of long COVID with health-related quality-of-life outcomes
Malini M Gandhi, Carlee Moser, Judith S Currier, et al.
Annals of Internal Medicine
|
February 21, 2023
Symptom and Viral Rebound in Untreated SARS-CoV-2 Infection
Rinki Deo, Manish C Choudhary, Carlee Moser, et al.
Clinical Pharmacology and Therapeutics
|
July 7, 2022
Comparative Pharmacokinetics of Tixagevimab/Cilgavimab (AZD7442) Administered Intravenously Versus Intramuscularly in Symptomatic SARS-CoV-2 Infection
Rachel A Bender Ignacio, David A Wohl, Rosalin Arends, et al.
Medrxiv : the Preprint Server for Health Sciences
|
August 19, 2022
Viral and Symptom Rebound in Untreated COVID-19 Infection
Rinki Deo, Manish C Choudhary, Carlee Moser, et al.
Medrxiv : the Preprint Server for Health Sciences
|
March 30, 2023
Statistical Challenges when Analyzing SARS-CoV-2 RNA Measurements Below the Assay Limit of Quantification in COVID-19 Clinical Trials
Carlee B Moser, Kara W Chew, Mark J Giganti, et al.
The Journal of Infectious Diseases
|
October 14, 2024
Viral and Symptom Rebound Following Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Monoclonal Antibody Therapy in a Randomized Placebo-Controlled Trial
Kara W Chew, Brooke McGinley, Carlee Moser, et al.
Eclinicalmedicine
|
September 10, 2024
Post-acute COVID-19 outcomes including participant-reported long COVID: amubarvimab/romlusevimab versus placebo in the ACTIV-2 trial
Teresa H Evering, Carlee Moser, Nikolaus Jilg, et al.
Science Immunology
|
March 27, 2021
A tumor-specific mechanism of T<sub>reg</sub> enrichment mediated by the integrin αvβ8
Robert I Seed, Kenji Kobayashi, Saburo Ito, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 17, 2024
SARS-CoV-2 Plasma Antibody and Nucleocapsid Antigen Status Predict Outcomes in Outpatients With COVID-19
Nikolaus Jilg, Mark J Giganti, Kara W Chew, et al.
Plos Pathogens
|
April 18, 2024
Modeling the emergence of viral resistance for SARS-CoV-2 during treatment with an anti-spike monoclonal antibody
Tin Phan, Carolin Zitzmann, Kara W Chew, et al.
Page
of 22